SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-13-019967
Filing Date
2013-05-10
Accepted
2013-05-10 12:41:22
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 3-31-2013 form10q.htm 10-Q 435777
2 EXHIBIT 31 ex31.htm EX-31 16303
3 EXHIBIT 32 ex32.htm EX-32 7339
  Complete submission text file 0001140361-13-019967.txt   2863679

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20130331.xml EX-101.INS 307074
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bstc-20130331.xsd EX-101.SCH 22247
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bstc-20130331_cal.xml EX-101.CAL 36445
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bstc-20130331_def.xml EX-101.DEF 48431
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bstc-20130331_lab.xml EX-101.LAB 304573
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bstc-20130331_pre.xml EX-101.PRE 178719
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 13832190
SIC: 2834 Pharmaceutical Preparations